Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: MITOSOL — Supplemental Application (Mobius Therapeutics LLC)

View source ↗

Summary

The FDA approved a supplemental application for MITOSOL (mitomycin) from Mobius Therapeutics LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MITOSOL (Mitomycin)

Snippet

SUPPL AP for MITOSOL (MITOMYCIN)